AstraZeneca Announced Acquisition on March 19
AstraZeneca Announced Acquisition on March 19
AstraZeneca Acquires Fusion Pharmaceuticals in $2.4 Billion Deal
AstraZeneca (AZN.L, AZN.ST) completed the acquisition of Fusion Pharmaceuticals for a maximum transaction value of $2.4 billion, according to a Tuesday release. The clinical-stage biopharmaceutical co
Fusion Pharmaceuticals Says $2.4 Billion Acquisition by AstraZeneca Unit Is Complete
Fusion Pharmaceuticals (FUSN) said late Tuesday its $2.4 billion acquisition by an AstraZeneca (AZN) subsidiary was completed. The deal "marks a major step forward" in AstraZeneca's ambition to transf
News On Fusion Pharmaceuticals Inc. (FUSN) Now Under AZN.LN
News On Fusion Pharmaceuticals Inc. (FUSN) Now Under AZN.LN
Express News | AstraZeneca Buys Fusion Pharma for $21 per Share in Cash
Express News | Acquisition of Fusion Pharmaceuticals Completed
Fusion Honored With Philanthropy Award From Greater Omaha Chamber
ELKHORN, Neb., June 3, 2024 /PRNewswire/ -- Omaha-based healthcare company Fusion is being honored for the company's dedication to its core purpose of improving the lives of everyone the company touc
Ontario Court Approves AstraZeneca/Fusion Acquisition Plan
Express News | Fusion Pharmaceuticals Obtains Final Court Approval For Acquisition By AstraZeneca Subsidiary; Shareholders To Receive $21/Share Plus $3 Contingent Value Right
Fusion Pharmaceuticals Shareholders to Get Deferred Payment in Form of Contingent Value Right of $3/Shr If Milestone Is Achieved >FUSN
Fusion Pharmaceuticals Shareholders to Get Deferred Payment in Form of Contingent Value Right of $3/Shr If Milestone Is Achieved >FUSN
Express News | Fusion Pharmaceuticals Inc - Fusion Shareholders Will Receive US$21.00 per Share in Cash Upfront on Completion of Arrangement
Express News | Fusion Pharmaceuticals Inc - Pursuant to Plan, a Wholly-Owned Subsidiary of AstraZeneca Will Acquire All Issued and Outstanding Shares of Fusion
Express News | Fusion Pharmaceuticals - Obtained Final Order From Ontario Superior Court of Justice Approving Previously Announced Statutory Plan of Arrangement
Express News | Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Fusion Pharmaceuticals Shareholders Back Major AstraZenica Deal
Express News | Fusion Pharmaceuticals Shareholders Approve Acquisition by AstraZeneca
Express News | Fusion Pharmaceuticals Announces First Patient Dosed in the Phase 2 Portion of the Alphabreak Trial Evaluating Fpi-2265 in Metastatic Castration-Resistant Prostate Cancer
Omaha Healthcare Company Fusion Announces Nursing Scholarship Winners
OMAHA, Neb., May 9, 2024 /PRNewswire/ -- Omaha-based healthcare company Fusion is announcing the 10 winners of the Compassion in Care – A Fusion Scholarship, aiming to assist students pursuing their
RBC Capital Remains a Hold on Fusion Pharmaceuticals (FUSN)
Fusion Pharmaceuticals Inc. Grapples With Tax Uncertainty: Potential Impacts on Finances and Investor Trust
No Data